ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Louisiana » Internal Medicine

Top Internal Medicine Prescribers in Louisiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID MYERS

Internal Medicine

43,289

$2.84M

1050
936 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 26%

$66
Average prescription price

Avg: $59

NICHOLAS CAMPO MD

Internal Medicine

43,135

$2.96M

1044
720 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

26%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 26%

$69
Average prescription price

Avg: $59

RUSSELL HENRY M.D.

Internal Medicine

40,672

$2.22M

1501
1259 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $59

PARIMAL PARIKH M D

Internal Medicine

40,339

$2.39M

775
672 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $59

RONALD LAHASKY M.D.

Internal Medicine

37,962

$1.91M

1086
946 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 14%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $59

BRIAN GREMILLION M.D.

Internal Medicine

36,103

$2.52M

1222
952 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$70
Average prescription price

Avg: $59

DARREN DRUMMOND MD

Internal Medicine

33,845

$1.69M

1046
794 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $59

BRUCE BARTON MD

Internal Medicine

33,612

$2.42M

1077
767 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 14%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$72
Average prescription price

Avg: $59

JALAL JOUDEH M.D.

Internal Medicine

30,020

$1.65M

674
472 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

32%
patients receiving schedule three controlled substances

Avg: 14%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $59

AMIR AUSEF MD

Internal Medicine

29,880

$2M

561
491 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 26%

$67
Average prescription price

Avg: $59

JEFFERY LAFLEUR M.D.

Internal Medicine

28,945

$1.72M

647
343 are 65+

23%
patients receiving schedule two controlled substances

Avg: 3%

46%
patients receiving schedule three controlled substances

Avg: 14%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $59

PAUL PARKER MD

Internal Medicine

28,780

$1.73M

817
713 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $59

OTIS BARNUM DO

Internal Medicine

26,016

$1.41M

660
547 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 14%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $59

BRENT ARDOIN M.D.

Internal Medicine

25,982

$1.19M

575
435 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

30%
patients receiving schedule three controlled substances

Avg: 14%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $59

PATRICK GRIFFITH MD

Internal Medicine

25,752

$1.19M

799
691 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $59

RON HAYS MD

Internal Medicine

25,308

$1.64M

577
483 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $59

CLARENCE TEAGLE MD

Internal Medicine

25,268

$1.44M

721
633 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 14%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $59

GERARD FALGOUST M.D.

Internal Medicine

25,215

$1.43M

893
718 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $59

CHRISTY GRAVES M.D.

Internal Medicine

24,738

$1.81M

665
529 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 26%

$73
Average prescription price

Avg: $59

SATINDER SAINI M.D.

Internal Medicine

24,533

$1.2M

650
471 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

30%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $59

KYLE CAULFIELD MD

Internal Medicine

24,318

$1.29M

742
604 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

28%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $59

LAWRENCE LEVY MD

Internal Medicine

24,242

$1.53M

1650
1456 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $59

KEITH HOLMES M.D.

Internal Medicine

23,660

$1M

1034
920 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 26%

$42
Average prescription price

Avg: $59

GAYATHRI TALLURI MD

Internal Medicine

23,235

$1.28M

1169
710 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $59

RAJENDRA GANDHI MD

Internal Medicine

23,167

$1.47M

839
592 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

28%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $59

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank